CYNTHIA NGUYEN: Open Payments
NPI 1417735390 · SUGAR LAND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$635 in 24 payments from 9 companies in 2025. Trend: 2023 $407 · 2024 $1,716 · 2025 $635
Food & beverage: $635
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 11 | $291 |
| AstraZeneca Pharmaceuticals LP | 4 | $147 |
| Grifols USA, LLC | 2 | $48 |
| GlaxoSmithKline, LLC. | 2 | $45 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $29 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $22 |
| Amgen Inc. | 1 | $19 |
| Seqirus USA Inc | 1 | $17 |
| PFIZER INC. | 1 | $17 |
Products named: DUPIXENT, TEZSPIRE, AIRSUPRA, Xembify, TRELEGY ELLIPTA, CUVITRU, NEFFY, Fluad.
Industry payments across TX — which companies pay providers there.
